Skip to main content
NCBI home page
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1986 Mar;13(1):61–67.

Combined Effect of Glucose and Verapamil in Experimental Cardioplegia

Edith Hochhauser 1, Yaacov Barak 1, Shmuel Einav 1, Sasson Cohen 1, Bernardo Vidne 1
PMCID: PMC324599  PMID: 15226833

Abstract

In this study, we determined whether pre-ischemic enhancement of the ATP level and the addition of verapamil (a calcium blocker) to the cardioplegic solution could improve myocardial protection during cardiac arrest. Using the Langendorff preparation of the isolated rat heart plus different cardioplegic solutions, five groups of normal rat hearts and five groups of hypertrophied rat hearts were subjected to 90-minute ischemic periods at 28° ± 1 and reperfusion of 30 minutes at 37° C. Group A received no cardioplegic solution; Group B received KCl, 30 mEq/L; Group C received type B perfusion with verapamil; and Group D received 15 minutes of pre-ischemic oxygenated enhancement perfusion containing KCl, 30 mEq/L, and glucose as substrate at 37° C. Group E received the same perfusion as Group D, with the addition of verapamil to the enhancement perfusion. Light and E/M microscopy was performed on representative samples of left ventricular muscle. We found that pre-ischemic enhancement with KCl, glucose, and verapamil was only protective in the normal hearts after 90 minutes of ischemia. In hypertrophied hearts, the addition of verapamil to the enhancement solution was harmful. The use of pre-ischemic enhancement solution without verapamil provided the best myocardial protection after 90 minutes of ischemia in the hypertrophied hearts.

Full text

PDF
61

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson H. T., Kessinger J. M., McFarland W. J., Jr, Laks H., Geha A. S. Response of the hypertrophied heart to acute anemia and coronary stenosis. Surgery. 1978 Jul;84(1):8–15. [PubMed] [Google Scholar]
  2. Buckberg G. D. Left ventricular subendocardial necrosis. Ann Thorac Surg. 1977 Oct;24(4):379–393. doi: 10.1016/s0003-4975(10)63418-2. [DOI] [PubMed] [Google Scholar]
  3. Hearse D. J., Garlick P. B., Humphrey S. M. Ischemic contracture of the myocardium: mechanisms and prevention. Am J Cardiol. 1977 Jun;39(7):986–993. doi: 10.1016/s0002-9149(77)80212-9. [DOI] [PubMed] [Google Scholar]
  4. Jacocks M. A., Fowler B. N., Chaffin J. S., Lowenstein E., Lappas D. G., Pohost G. M., Boucher C. A., Okada R. D., Hanna N., Daggett W. M. Hypothermic ischemic arrest versus hypothermic potassium cardioplegia in human beings. Ann Thorac Surg. 1982 Aug;34(2):157–165. doi: 10.1016/s0003-4975(10)60877-6. [DOI] [PubMed] [Google Scholar]
  5. Nayler W. G., Grau A., Slade A. A protective effect of verapamil on hypoxic heart muscle. Cardiovasc Res. 1976 Nov;10(6):650–662. doi: 10.1093/cvr/10.6.650. [DOI] [PubMed] [Google Scholar]
  6. Nayler W. G. The role of calcium in the ischemic myocardium. Am J Pathol. 1981 Feb;102(2):262–270. [PMC free article] [PubMed] [Google Scholar]
  7. Neely J. R., Liebermeister H., Battersby E. J., Morgan H. E. Effect of pressure development on oxygen consumption by isolated rat heart. Am J Physiol. 1967 Apr;212(4):804–814. doi: 10.1152/ajplegacy.1967.212.4.804. [DOI] [PubMed] [Google Scholar]
  8. Pernot A. C., Ingwall J. S., Menasche P., Grousset C., Bercot M., Mollet M., Piwnica A., Fossel E. T. Limitations of potassium cardioplegia during cardiac ischemic arrest: a phosphorus 31 nuclear magnetic resonance study. Ann Thorac Surg. 1981 Dec;32(6):536–545. doi: 10.1016/s0003-4975(10)61794-8. [DOI] [PubMed] [Google Scholar]
  9. Peyton R. B., Van Trigt P., Pellom G. L., Jones R. N., Sink J. D., Wechsler A. S. Improved tolerance to ischemia in hypertrophied myocardium by preischemic enhancement of adenosine triphosphate. J Thorac Cardiovasc Surg. 1982 Jul;84(1):11–15. [PubMed] [Google Scholar]
  10. Reimer K. A., Jennings R. B. Effects of calcium-channel blockers on myocardial preservation during experimental acute myocardial infarction. Am J Cardiol. 1985 Jan 25;55(3):107B–115B. doi: 10.1016/0002-9149(85)90619-8. [DOI] [PubMed] [Google Scholar]
  11. Rich T. L., Brady A. J. Potassium contracture and utilization of high-energy phosphates in rabbit heart. Am J Physiol. 1974 Jan;226(1):105–113. doi: 10.1152/ajplegacy.1974.226.1.105. [DOI] [PubMed] [Google Scholar]
  12. Sink J. D., Pellom G. L., Currie W. D., Hill R. C., Olsen C. O., Jones R. N., Wechsler A. S. Response of hypertrophied myocardium to ischemia: correlation with biochemical and physiological parameters. J Thorac Cardiovasc Surg. 1981 Jun;81(6):865–872. [PubMed] [Google Scholar]
  13. Yamamoto F., Manning A. S., Braimbridge M. V., Hearse D. J. Cardioplegia and slow calcium-channel blockers. Studies with verapamil. J Thorac Cardiovasc Surg. 1983 Aug;86(2):252–261. [PubMed] [Google Scholar]
  14. Zsotér T. T., Church J. G. Calcium antagonists. Pharmacodynamic effects and mechanism of action. Drugs. 1983 Feb;25(2):93–112. doi: 10.2165/00003495-198325020-00001. [DOI] [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES